NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
The United States is in the midst of a horrific problem. The rampant misuse of opioid drugs (both prescribed and illegal), now known as the Opioid Crisis, has had grave effects on both the public health and the well-being of our society. In 1 year, 2017, it is estimated that almost as many Americans died from opioid-related overdose as died in the entire Vietnam War [ 1 ]. In response to the problem, the White House has declared the Opioid Crisis a national Public Health Emergency under federal law [ 2 ].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although the task to develop novel treatments is challenging, promising candidates await evaluation [53].”
From Addiction as a brain disease revised: why it still matters, and the need for consilience (2021) · doi:10.1038/s41386-020-00950-y · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 44 · Cited by 128
Metadata
- Authors
- Rasmussen, K., White, D. A., & Acri, J. B.
- Affiliations
- National Institutes of Health (US)
- National Institute on Drug Abuse (US)
- Corresponding author
- Rasmussen, Kurt
- Venue
- Neuropsychopharmacology
- Published
- 2018-12-07
- Volume
- 44
- Issue
- 4
- Pages
- 657-659
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- PMC
- PMC6372702
- OpenAlex
- W2904830602
- Cited by
- 128
- References
- 44
- Citations by year
- 2026: 15 · 2025: 11 · 2024: 18 · 2023: 23 · 2022: 20 · 2021: 17 · 2020: 16 · 2019: 8
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- opioid epidemic, opioid misuse, opioid overdose, National Institute on Drug Abuse, public health emergencies, opioid-related deaths, prescription opioids, illicit opioids
- MeSH terms
- Drug Development, Humans, Opioid-Related Disorders, United States, National Institute on Drug Abuse (U.S.), Drug Overdose, Prescription Drug Misuse
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted. https://app.cochat.ai/papers/10.1038/s41386-018-0292-5
- The paper
- Rasmussen, K., White, D. A., & Acri, J. B. (2019). NIDA’s medication development priorities in response to the Opioid Crisis: ten most wanted. Neuropsychopharmacology. https://doi.org/10.1038/s41386-018-0292-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.